Freyr’s global engagements is a growing list of $10+ Billion accounts including 6 of the Forbes Global Top 10 Pharma, 3 of the Forbes Global Top 7 Healthcare, 2 of the Forbes Global Top 6 Biotech and many $1 Million to $10 Billion Fast growing global Life Sciences, CROs and Standards companies.
Freyr is supporting the global engagements with end-to-end Global Regulatory responsibility enabling significant savings of over 40% year-on-year in cost of compliance.
Freyr’s centralized Regulatory CoE is providing strategic Regulatory Consulting, Operations and Technology Services as well as the global delivery of end-to-end Regulatory Affairs and Regulatory Operations Services to the companies.
Dedicated Global Teams have been set up and are supporting with the fulfilment of critical Health Directive Mandates for the engagements across multiple geographies that include – North America & EU, Asia-Pac, MEA, CIS, Australia.
Freyr’s Onsite Delivery & Program Management Teams based out of US and UK cover the time zones and ensure 24×7 services for Global Business Units.
Wide Ranging Regulatory Expertise
- End-to-end Regulatory Product responsibility
- Regulatory Affairs
- CMC & Change Control
- Labeling & Artwork (Copy Development, Proof reading, Label Management)
- Submission Publishing
- Process & SOP Harmonization
- Clinical Study Reports
- Regulatory Tracking & Intelligence
- Regulatory Information Management
- Compliance Software Solutions
Improved Process Efficiency via Process Standardization Best PracticesFreyr supports successful centralization of activities across multiple markets leading to cost optimization of compliance.